Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

The diagnosis of hereditary hemorrhagic telangiectasia (HHT) is based on the Curaçao criteria: epistaxis, telangiectases, arteriovenous malformations in internal organs, and family history. Genetically speaking, more than 90% of HHT patients show mutations in ENG or ACVRL1/ALK1 genes, both belonging...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Albiñana, Virginia, Cuesta, Angel M., de Rojas-P, Isabel, Gallardo-Vara, Eunate, Recio-Poveda, Lucía, Bernabéu, Carmelo, Botella, Luisa María
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356836/
https://ncbi.nlm.nih.gov/pubmed/32517280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061766
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars